What is ZVIA's health score?

Zevia PBC (ZVIA) has a TradeApes health score of 45 out of 100, rated Mixed. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is ZVIA's estimated fair value?

Based on our 5-year discounted cash flow model, Zevia PBC's estimated fair value is $2.21 per share, representing a 42.6% upside from the current price. This is a model estimate, not a price target or investment recommendation.

Is ZVIA undervalued or overvalued?

Our model currently rates ZVIA as Undervalued. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for ZVIA... Refresh in a moment for the full analysis.

Zevia PBC (ZVIA)

Consumer Defensive Undervalued low mixed

$1.55

Updated: 2026-05-30

TradeApes Score

Financial Strength

35 Weak

Operating Trend

40 Weak

Relative Value

40 Weak

Capital Allocation

55 Mixed

Risk

80 Strong

Est. Fair Value $2.21

DCF Upside +42.6%

Sector Rank #98 of 816

Key Findings

+ Strong liquidity — current assets more than 2× current liabilities

Unlock Full Report →

− High leverage — net debt/EBITDA between 3× and 5×

Unlock Full Report →

Create an account for unlimited access

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.